21 November 2017
News and Views
Links and Services
This week's New England Journal of Medicine investigates eltrombopag for thrombocytopenia in cirrhosis associated with Hepatitis C.
Eltrombopag is a new, orally active thrombopoietin-receptor agonist that stimulates thrombopoiesi
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors